衛生福利部桃園醫院是中華民國衛生福利部設於桃園市的所屬醫院，於1979年設立。另設有新屋分院。

During the past decade, Taoyuan General Hospital, Ministry of Health and Welfare conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taoyuan General Hospital, Ministry of Health and Welfare" #1 sponsor was "Taoyuan General Hospital" with 9 trials, followed by "Medigen Vaccine Biologics Corp." with 2 trials sponsored, "National Health Research Institutes, Taiwan" with 2 trials sponsored, "Chang Gung University" with 1 trials sponsored and "Far Eastern Memorial Hospital" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taoyuan General Hospital, Ministry of Health and Welfare" #1 collaborator was "National Taiwan University Hospital" with 3 trials as a collaborator, "Chang Gung Memorial Hospital" with 2 trials as a collaborator, "China Medical University Hospital" with 2 trials as a collaborator, "Kaohsiung Medical University Chung-Ho Memorial Hospital" with 2 trials as a collaborator and "National Cheng-Kung University Hospital" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Taoyuan General Hospital, Ministry of Health and Welfare" are "Covid19 Vaccine" (2 trials), "Acute Coronary Syndrome" (1 trials), "Biliary Tract Cancer (BTC)" (1 trials), "Birth; Delayed" (1 trials) and "COVID-19 Vaccine" (1 trials). Many other conditions were trialed in "Taoyuan General Hospital, Ministry of Health and Welfare" in a lesser frequency.

Most popular intervention types in "Taoyuan General Hospital, Ministry of Health and Welfare" are "Other" (7 trials), "Biological" (3 trials), "Drug" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "MVC-COV1901(S protein with adjuvant)" (2 trials), "placebo" (2 trials), "Cervical Cranioflexion exercise plus cardiopulmonary exercise" (1 trials), "Cervical stretch exercise plus cardiopulmonary rehabilitation" (1 trials) and "Failing ARV Regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taoyuan General Hospital, Ministry of Health and Welfare" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Taoyuan General Hospital, Ministry of Health and Welfare". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Taoyuan General Hospital, Ministry of Health and Welfare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Taoyuan General Hospital, Ministry of Health and Welfare, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".